GSK Bribery Conviction Signals Increased Risks In China
On Sept. 19, 2014, a Chinese court found pharmaceutical giant GlaxoSmithKline PLC guilty of bribing doctors and hospitals in order to increase sales of the company's products in China. Among other...To view the full article, register now.
Already a subscriber? Click here to view full article